Beauty Health assumed with a Buy at Canaccord

Canaccord analyst Susan Anderson assumed coverage of Beauty Health with a Buy rating and $10 price target. The company is the creator of the Hydrafacial platform, a noninvasive aesthetic procedure that helps with skin health, the analyst tells investors in a research note. The firm believes the shares have “significant upside potentia”l as management continues to expand the platform to new providers, upgrades existing customers to the newest Syndeo systems, and executes on its long term goals.